Qatar Pharmaceuticals & Healthcare Report Q4 2014: New Research Report Available at Fast Market Research
The reduction of a large number of medicine prices in Qatar is likely to be detrimental to pharmaceutical companies' revenue potential. New drug pricing - which was previously very high in the country - will increase the volume of sales, as medicines will become more affordable, partially counteracting losses from price reduction. Economic and political stability, in addition to projected growth in the pharmaceutical and healthcare markets, will ensure that Qatar remains a small but attractive market.
View full press release